Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Moisse

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Acta Neuropathologica Communications|July 7, 2019
Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse modelElisabeth Rossaert, Eveliina Pollari, Tom Jaspers, et al.
Environment International|April 8, 2018
Global and gene-specific DNA methylation effects of different asbestos fibres on human bronchial epithelial cellsDeniz Öner, Manosij Ghosh, Matthieu Moisse, et al.
European Journal of Neurology|September 1, 2021
RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvementSien H Van Daele, Matthieu Moisse, Valérie Race, et al.
Neurobiology of Aging|September 23, 2017
NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patientsHung Phuoc Nguyen, Sara Van Mossevelde, Lubina Dillen, et al.
Laboratory Medicine|October 23, 2015
Expression of FOXP1 and Colorectal Cancer PrognosisLinde De Smedt, Sofie Palmans, Olivier Govaere, et al.
British Journal of Cancer|September 11, 2015
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line settingDiether Lambrechts, Bernard Thienpont, Vincent Thuillier, et al.
Radiation Oncology (London, England)|July 19, 2018
RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissueKobe Reynders, Els Wauters, Matthieu Moisse, et al.
Angiogenesis|July 12, 2014
Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapySanne de Haas, Paul Delmar, Aruna T Bansal, et al.
Angiogenesis|February 22, 2014
Genetic markers of bevacizumab-induced hypertensionDiether Lambrechts, Matthieu Moisse, Paul Delmar, et al.
Gynecologic Oncology|October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancerEvelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Acta Neuropathologica Communications|July 7, 2019
Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse modelElisabeth Rossaert, Eveliina Pollari, Tom Jaspers, et al.
Environment International|April 8, 2018
Global and gene-specific DNA methylation effects of different asbestos fibres on human bronchial epithelial cellsDeniz Öner, Manosij Ghosh, Matthieu Moisse, et al.
European Journal of Neurology|September 1, 2021
RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvementSien H Van Daele, Matthieu Moisse, Valérie Race, et al.
Neurobiology of Aging|September 23, 2017
NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patientsHung Phuoc Nguyen, Sara Van Mossevelde, Lubina Dillen, et al.
Laboratory Medicine|October 23, 2015
Expression of FOXP1 and Colorectal Cancer PrognosisLinde De Smedt, Sofie Palmans, Olivier Govaere, et al.
British Journal of Cancer|September 11, 2015
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line settingDiether Lambrechts, Bernard Thienpont, Vincent Thuillier, et al.
Radiation Oncology (London, England)|July 19, 2018
RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissueKobe Reynders, Els Wauters, Matthieu Moisse, et al.
Angiogenesis|July 12, 2014
Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapySanne de Haas, Paul Delmar, Aruna T Bansal, et al.
Angiogenesis|February 22, 2014
Genetic markers of bevacizumab-induced hypertensionDiether Lambrechts, Matthieu Moisse, Paul Delmar, et al.
Gynecologic Oncology|October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancerEvelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
Pageof 7